Radioresistant Nasopharyngeal Carcinoma Cells Exhibited Decreased Cisplatin Sensitivity by Inducing SLC1A6 Expression

Cisplatin-based regimens are commonly used for the treatment of nasopharyngeal carcinoma (NPC) in patients who receive concurrent chemoradiotherapy. The sensitivity of NPC cells to cisplatin is closely associated with the efficacy of radiation therapy. In this study, we established two radioresistan...

Descripción completa

Detalles Bibliográficos
Autores principales: Hao, Wenwen, Wu, Lisha, Cao, Linhui, Yu, Jinxiu, Ning, Li, Wang, Jingshu, Lin, Xiaoping, Chen, Yanfeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8077170/
https://www.ncbi.nlm.nih.gov/pubmed/33927617
http://dx.doi.org/10.3389/fphar.2021.629264

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8077170/
https://www.ncbi.nlm.nih.gov/pubmed/33927617
http://dx.doi.org/10.3389/fphar.2021.629264

Ejemplares similares